FDA advisers vote in favor of Pfizer’s maternal RSV vaccine
May 18, 2023 at 18:10 PM EDT
If approved, vaccine would be the first in U.S. to protect babies against leading cause of hospitalization
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|